1. Home
  2. Labeler Index
  3. Chiesi Usa, Inc.
  4. 10122-180
  5. NDC Package Code: 10122-180-05 Lamzede

NDC Package 10122-180-05 Lamzede

Velmanase Alfa-tycv Injection, Powder, Lyophilized, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
10122-180-05
Package Description:
5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON
Product Code:
10122-180
Proprietary Name:
Lamzede
Non-Proprietary Name:
Velmanase Alfa-tycv
Substance Name:
Velmanase Alfa-tycv
Usage Information:
LAMZEDE is indicated for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients.
11-Digit NDC Billing Format:
10122018005
NDC to RxNorm Crosswalk:
  • RxCUI: 2630729 - velmanase alfa-tycv 10 MG Injection
  • RxCUI: 2630734 - Lamzede 10 MG Injection
  • RxCUI: 2630734 - velmanase alfa-tycv 10 MG Injection [Lamzede]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Chiesi Usa, Inc.
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • VELMANASE ALFA-TYCV 10 mg/1
    • Sample Package:
    No
    FDA Application Number:
    BLA761278
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    03-01-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 10122-180-05 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    10122018005J0217Inj velmanase alfa-tycv 1 mg1 MG151050

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    10122-180-021 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON
    10122-180-1010 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 10122-180-05?

    The NDC Packaged Code 10122-180-05 is assigned to a package of 5 injection, powder, lyophilized, for solution in 1 carton of Lamzede, a human prescription drug labeled by Chiesi Usa, Inc.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.

    Is NDC 10122-180 included in the NDC Directory?

    Yes, Lamzede with product code 10122-180 is active and included in the NDC Directory. The product was first marketed by Chiesi Usa, Inc. on March 01, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 10122-180-05?

    The 11-digit format is 10122018005. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-210122-180-055-4-210122-0180-05